nodes	percent_of_prediction	percent_of_DWPC	metapath
Silodosin—CYP3A4—type 2 diabetes mellitus	0.2	1	CbGaD
Silodosin—ADRA1D—Bromocriptine—type 2 diabetes mellitus	0.0783	0.148	CbGbCtD
Silodosin—UGT2B7—Losartan—type 2 diabetes mellitus	0.0658	0.125	CbGbCtD
Silodosin—ADRA1B—Bromocriptine—type 2 diabetes mellitus	0.057	0.108	CbGbCtD
Silodosin—ADRA1A—Bromocriptine—type 2 diabetes mellitus	0.045	0.0852	CbGbCtD
Silodosin—ABCB1—Linagliptin—type 2 diabetes mellitus	0.0374	0.0708	CbGbCtD
Silodosin—ABCB1—Sitagliptin—type 2 diabetes mellitus	0.0333	0.0631	CbGbCtD
Silodosin—ABCB1—Chlorpropamide—type 2 diabetes mellitus	0.0241	0.0456	CbGbCtD
Silodosin—CYP3A4—Linagliptin—type 2 diabetes mellitus	0.0224	0.0424	CbGbCtD
Silodosin—CYP3A4—Sitagliptin—type 2 diabetes mellitus	0.02	0.0378	CbGbCtD
Silodosin—CYP3A4—Glipizide—type 2 diabetes mellitus	0.0183	0.0346	CbGbCtD
Silodosin—ABCB1—Bromocriptine—type 2 diabetes mellitus	0.0166	0.0314	CbGbCtD
Silodosin—CYP3A4—Repaglinide—type 2 diabetes mellitus	0.016	0.0302	CbGbCtD
Silodosin—CYP3A4—Pioglitazone—type 2 diabetes mellitus	0.0144	0.0273	CbGbCtD
Silodosin—ABCB1—Glyburide—type 2 diabetes mellitus	0.0123	0.0234	CbGbCtD
Silodosin—ABCB1—Losartan—type 2 diabetes mellitus	0.0113	0.0214	CbGbCtD
Silodosin—CYP3A4—Nateglinide—type 2 diabetes mellitus	0.0109	0.0207	CbGbCtD
Silodosin—CYP3A4—Irbesartan—type 2 diabetes mellitus	0.0105	0.0199	CbGbCtD
Silodosin—CYP3A4—Orlistat—type 2 diabetes mellitus	0.0105	0.0199	CbGbCtD
Silodosin—CYP3A4—Bromocriptine—type 2 diabetes mellitus	0.00992	0.0188	CbGbCtD
Silodosin—CYP3A4—Glyburide—type 2 diabetes mellitus	0.00739	0.014	CbGbCtD
Silodosin—CYP3A4—Losartan—type 2 diabetes mellitus	0.00676	0.0128	CbGbCtD
Silodosin—Tamsulosin—ADRA2A—type 2 diabetes mellitus	0.00155	0.685	CrCbGaD
Silodosin—Tamsulosin—CYP3A4—type 2 diabetes mellitus	0.000714	0.315	CrCbGaD
Silodosin—Skin disorder—Bromocriptine—type 2 diabetes mellitus	0.000326	0.00203	CcSEcCtD
Silodosin—Gastrointestinal pain—Glipizide—type 2 diabetes mellitus	0.000326	0.00203	CcSEcCtD
Silodosin—Angiopathy—Valsartan—type 2 diabetes mellitus	0.000323	0.00201	CcSEcCtD
Silodosin—Breast disorder—Ramipril—type 2 diabetes mellitus	0.000322	0.00201	CcSEcCtD
Silodosin—Hepatobiliary disease—Irbesartan—type 2 diabetes mellitus	0.000322	0.00201	CcSEcCtD
Silodosin—Pruritus—Rosiglitazone—type 2 diabetes mellitus	0.000322	0.00201	CcSEcCtD
Silodosin—Immune system disorder—Valsartan—type 2 diabetes mellitus	0.000322	0.00201	CcSEcCtD
Silodosin—Gastrointestinal disorder—Glimepiride—type 2 diabetes mellitus	0.000321	0.002	CcSEcCtD
Silodosin—Mediastinal disorder—Valsartan—type 2 diabetes mellitus	0.000321	0.002	CcSEcCtD
Silodosin—Gastrointestinal disorder—Sitagliptin—type 2 diabetes mellitus	0.00032	0.002	CcSEcCtD
Silodosin—Immune system disorder—Orlistat—type 2 diabetes mellitus	0.000318	0.00198	CcSEcCtD
Silodosin—Mediastinal disorder—Orlistat—type 2 diabetes mellitus	0.000317	0.00198	CcSEcCtD
Silodosin—Urticaria—Glipizide—type 2 diabetes mellitus	0.000316	0.00197	CcSEcCtD
Silodosin—Abdominal pain—Glipizide—type 2 diabetes mellitus	0.000315	0.00196	CcSEcCtD
Silodosin—Hypotension—Bromocriptine—type 2 diabetes mellitus	0.000313	0.00195	CcSEcCtD
Silodosin—Jaundice—Losartan—type 2 diabetes mellitus	0.000313	0.00195	CcSEcCtD
Silodosin—Mental disorder—Valsartan—type 2 diabetes mellitus	0.000312	0.00195	CcSEcCtD
Silodosin—Diarrhoea—Rosiglitazone—type 2 diabetes mellitus	0.000311	0.00194	CcSEcCtD
Silodosin—Mental disorder—Orlistat—type 2 diabetes mellitus	0.000308	0.00192	CcSEcCtD
Silodosin—Gastrointestinal pain—Glimepiride—type 2 diabetes mellitus	0.000304	0.0019	CcSEcCtD
Silodosin—Rash—Repaglinide—type 2 diabetes mellitus	0.000304	0.00189	CcSEcCtD
Silodosin—Insomnia—Bromocriptine—type 2 diabetes mellitus	0.000303	0.00189	CcSEcCtD
Silodosin—Dermatitis—Repaglinide—type 2 diabetes mellitus	0.000303	0.00189	CcSEcCtD
Silodosin—Urticaria—Pioglitazone—type 2 diabetes mellitus	0.000303	0.00189	CcSEcCtD
Silodosin—Gastrointestinal pain—Sitagliptin—type 2 diabetes mellitus	0.000303	0.00189	CcSEcCtD
Silodosin—Headache—Repaglinide—type 2 diabetes mellitus	0.000302	0.00188	CcSEcCtD
Silodosin—Shock—Glyburide—type 2 diabetes mellitus	0.000302	0.00188	CcSEcCtD
Silodosin—Dizziness—Rosiglitazone—type 2 diabetes mellitus	0.000301	0.00188	CcSEcCtD
Silodosin—Sinusitis—Losartan—type 2 diabetes mellitus	0.000301	0.00188	CcSEcCtD
Silodosin—Cardiac disorder—Metformin—type 2 diabetes mellitus	0.000301	0.00188	CcSEcCtD
Silodosin—Nervous system disorder—Glyburide—type 2 diabetes mellitus	0.000301	0.00188	CcSEcCtD
Silodosin—Palpitations—Gliclazide—type 2 diabetes mellitus	0.000298	0.00186	CcSEcCtD
Silodosin—Loss of consciousness—Gliclazide—type 2 diabetes mellitus	0.000296	0.00185	CcSEcCtD
Silodosin—Urticaria—Glimepiride—type 2 diabetes mellitus	0.000295	0.00184	CcSEcCtD
Silodosin—Urticaria—Sitagliptin—type 2 diabetes mellitus	0.000294	0.00184	CcSEcCtD
Silodosin—Angiopathy—Metformin—type 2 diabetes mellitus	0.000294	0.00183	CcSEcCtD
Silodosin—Abdominal pain—Glimepiride—type 2 diabetes mellitus	0.000294	0.00183	CcSEcCtD
Silodosin—Abdominal pain—Sitagliptin—type 2 diabetes mellitus	0.000293	0.00183	CcSEcCtD
Silodosin—Immune system disorder—Metformin—type 2 diabetes mellitus	0.000293	0.00183	CcSEcCtD
Silodosin—Mediastinal disorder—Metformin—type 2 diabetes mellitus	0.000292	0.00182	CcSEcCtD
Silodosin—Gastrointestinal disorder—Bromocriptine—type 2 diabetes mellitus	0.000289	0.00181	CcSEcCtD
Silodosin—Rash—Rosiglitazone—type 2 diabetes mellitus	0.000287	0.00179	CcSEcCtD
Silodosin—Dermatitis—Rosiglitazone—type 2 diabetes mellitus	0.000287	0.00179	CcSEcCtD
Silodosin—Hypotension—Glyburide—type 2 diabetes mellitus	0.000286	0.00179	CcSEcCtD
Silodosin—Nausea—Repaglinide—type 2 diabetes mellitus	0.000286	0.00178	CcSEcCtD
Silodosin—Asthenia—Glipizide—type 2 diabetes mellitus	0.000286	0.00178	CcSEcCtD
Silodosin—Unspecified disorder of skin and subcutaneous tissue—Gliclazide—type 2 diabetes mellitus	0.000285	0.00178	CcSEcCtD
Silodosin—Headache—Rosiglitazone—type 2 diabetes mellitus	0.000285	0.00178	CcSEcCtD
Silodosin—Erectile dysfunction—Ramipril—type 2 diabetes mellitus	0.000284	0.00177	CcSEcCtD
Silodosin—Cardiac disorder—Irbesartan—type 2 diabetes mellitus	0.000284	0.00177	CcSEcCtD
Silodosin—Pruritus—Glipizide—type 2 diabetes mellitus	0.000282	0.00176	CcSEcCtD
Silodosin—Dry mouth—Gliclazide—type 2 diabetes mellitus	0.000281	0.00175	CcSEcCtD
Silodosin—Syncope—Valsartan—type 2 diabetes mellitus	0.000278	0.00173	CcSEcCtD
Silodosin—Angiopathy—Irbesartan—type 2 diabetes mellitus	0.000278	0.00173	CcSEcCtD
Silodosin—Immune system disorder—Irbesartan—type 2 diabetes mellitus	0.000276	0.00172	CcSEcCtD
Silodosin—Mediastinal disorder—Irbesartan—type 2 diabetes mellitus	0.000276	0.00172	CcSEcCtD
Silodosin—Gastrointestinal pain—Bromocriptine—type 2 diabetes mellitus	0.000274	0.00171	CcSEcCtD
Silodosin—Palpitations—Valsartan—type 2 diabetes mellitus	0.000274	0.00171	CcSEcCtD
Silodosin—Asthenia—Pioglitazone—type 2 diabetes mellitus	0.000274	0.00171	CcSEcCtD
Silodosin—Diarrhoea—Glipizide—type 2 diabetes mellitus	0.000273	0.0017	CcSEcCtD
Silodosin—Loss of consciousness—Valsartan—type 2 diabetes mellitus	0.000272	0.0017	CcSEcCtD
Silodosin—Palpitations—Orlistat—type 2 diabetes mellitus	0.000271	0.00169	CcSEcCtD
Silodosin—Nausea—Rosiglitazone—type 2 diabetes mellitus	0.00027	0.00169	CcSEcCtD
Silodosin—Nervous system disorder—Gliclazide—type 2 diabetes mellitus	0.00027	0.00168	CcSEcCtD
Silodosin—Tachycardia—Gliclazide—type 2 diabetes mellitus	0.000269	0.00168	CcSEcCtD
Silodosin—Jaundice—Ramipril—type 2 diabetes mellitus	0.000268	0.00167	CcSEcCtD
Silodosin—Skin disorder—Gliclazide—type 2 diabetes mellitus	0.000267	0.00167	CcSEcCtD
Silodosin—Asthenia—Glimepiride—type 2 diabetes mellitus	0.000267	0.00166	CcSEcCtD
Silodosin—Urticaria—Bromocriptine—type 2 diabetes mellitus	0.000266	0.00166	CcSEcCtD
Silodosin—Asthenia—Sitagliptin—type 2 diabetes mellitus	0.000266	0.00166	CcSEcCtD
Silodosin—Abdominal pain—Bromocriptine—type 2 diabetes mellitus	0.000265	0.00165	CcSEcCtD
Silodosin—Gastrointestinal disorder—Glyburide—type 2 diabetes mellitus	0.000265	0.00165	CcSEcCtD
Silodosin—Dizziness—Glipizide—type 2 diabetes mellitus	0.000263	0.00164	CcSEcCtD
Silodosin—Pruritus—Glimepiride—type 2 diabetes mellitus	0.000263	0.00164	CcSEcCtD
Silodosin—Unspecified disorder of skin and subcutaneous tissue—Valsartan—type 2 diabetes mellitus	0.000262	0.00163	CcSEcCtD
Silodosin—Angiopathy—Losartan—type 2 diabetes mellitus	0.000261	0.00163	CcSEcCtD
Silodosin—Diarrhoea—Pioglitazone—type 2 diabetes mellitus	0.000261	0.00163	CcSEcCtD
Silodosin—Hepatobiliary disease—Ramipril—type 2 diabetes mellitus	0.00026	0.00162	CcSEcCtD
Silodosin—Unspecified disorder of skin and subcutaneous tissue—Orlistat—type 2 diabetes mellitus	0.000259	0.00162	CcSEcCtD
Silodosin—Dry mouth—Valsartan—type 2 diabetes mellitus	0.000258	0.00161	CcSEcCtD
Silodosin—Sinusitis—Ramipril—type 2 diabetes mellitus	0.000258	0.00161	CcSEcCtD
Silodosin—Hypotension—Gliclazide—type 2 diabetes mellitus	0.000257	0.0016	CcSEcCtD
Silodosin—Dry mouth—Orlistat—type 2 diabetes mellitus	0.000255	0.00159	CcSEcCtD
Silodosin—Diarrhoea—Glimepiride—type 2 diabetes mellitus	0.000254	0.00159	CcSEcCtD
Silodosin—Diarrhoea—Sitagliptin—type 2 diabetes mellitus	0.000254	0.00158	CcSEcCtD
Silodosin—Syncope—Metformin—type 2 diabetes mellitus	0.000253	0.00158	CcSEcCtD
Silodosin—Dizziness—Pioglitazone—type 2 diabetes mellitus	0.000252	0.00157	CcSEcCtD
Silodosin—Rash—Glipizide—type 2 diabetes mellitus	0.000251	0.00157	CcSEcCtD
Silodosin—Dermatitis—Glipizide—type 2 diabetes mellitus	0.000251	0.00157	CcSEcCtD
Silodosin—Gastrointestinal pain—Glyburide—type 2 diabetes mellitus	0.000251	0.00156	CcSEcCtD
Silodosin—Headache—Glipizide—type 2 diabetes mellitus	0.00025	0.00156	CcSEcCtD
Silodosin—Palpitations—Metformin—type 2 diabetes mellitus	0.000249	0.00156	CcSEcCtD
Silodosin—Insomnia—Gliclazide—type 2 diabetes mellitus	0.000249	0.00155	CcSEcCtD
Silodosin—Shock—Valsartan—type 2 diabetes mellitus	0.000249	0.00155	CcSEcCtD
Silodosin—Loss of consciousness—Metformin—type 2 diabetes mellitus	0.000248	0.00155	CcSEcCtD
Silodosin—Nervous system disorder—Valsartan—type 2 diabetes mellitus	0.000248	0.00155	CcSEcCtD
Silodosin—Dizziness—Glimepiride—type 2 diabetes mellitus	0.000246	0.00153	CcSEcCtD
Silodosin—Skin disorder—Valsartan—type 2 diabetes mellitus	0.000246	0.00153	CcSEcCtD
Silodosin—Nervous system disorder—Orlistat—type 2 diabetes mellitus	0.000245	0.00153	CcSEcCtD
Silodosin—Dizziness—Sitagliptin—type 2 diabetes mellitus	0.000245	0.00153	CcSEcCtD
Silodosin—Urticaria—Glyburide—type 2 diabetes mellitus	0.000244	0.00152	CcSEcCtD
Silodosin—Skin disorder—Orlistat—type 2 diabetes mellitus	0.000243	0.00151	CcSEcCtD
Silodosin—Abdominal pain—Glyburide—type 2 diabetes mellitus	0.000242	0.00151	CcSEcCtD
Silodosin—Asthenia—Bromocriptine—type 2 diabetes mellitus	0.000241	0.0015	CcSEcCtD
Silodosin—Headache—Pioglitazone—type 2 diabetes mellitus	0.000239	0.00149	CcSEcCtD
Silodosin—Syncope—Irbesartan—type 2 diabetes mellitus	0.000239	0.00149	CcSEcCtD
Silodosin—Unspecified disorder of skin and subcutaneous tissue—Metformin—type 2 diabetes mellitus	0.000239	0.00149	CcSEcCtD
Silodosin—Gastrointestinal disorder—Gliclazide—type 2 diabetes mellitus	0.000238	0.00148	CcSEcCtD
Silodosin—Nausea—Glipizide—type 2 diabetes mellitus	0.000237	0.00148	CcSEcCtD
Silodosin—Hypotension—Valsartan—type 2 diabetes mellitus	0.000236	0.00147	CcSEcCtD
Silodosin—Rash—Glimepiride—type 2 diabetes mellitus	0.000234	0.00146	CcSEcCtD
Silodosin—Dermatitis—Glimepiride—type 2 diabetes mellitus	0.000234	0.00146	CcSEcCtD
Silodosin—Loss of consciousness—Irbesartan—type 2 diabetes mellitus	0.000234	0.00146	CcSEcCtD
Silodosin—Rash—Sitagliptin—type 2 diabetes mellitus	0.000234	0.00146	CcSEcCtD
Silodosin—Dermatitis—Sitagliptin—type 2 diabetes mellitus	0.000233	0.00146	CcSEcCtD
Silodosin—Headache—Glimepiride—type 2 diabetes mellitus	0.000233	0.00145	CcSEcCtD
Silodosin—Headache—Sitagliptin—type 2 diabetes mellitus	0.000232	0.00145	CcSEcCtD
Silodosin—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	0.000229	0.00143	CcSEcCtD
Silodosin—Insomnia—Valsartan—type 2 diabetes mellitus	0.000229	0.00143	CcSEcCtD
Silodosin—Shock—Metformin—type 2 diabetes mellitus	0.000227	0.00141	CcSEcCtD
Silodosin—Insomnia—Orlistat—type 2 diabetes mellitus	0.000226	0.00141	CcSEcCtD
Silodosin—Nervous system disorder—Metformin—type 2 diabetes mellitus	0.000226	0.00141	CcSEcCtD
Silodosin—Unspecified disorder of skin and subcutaneous tissue—Irbesartan—type 2 diabetes mellitus	0.000225	0.0014	CcSEcCtD
Silodosin—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	0.000225	0.0014	CcSEcCtD
Silodosin—Syncope—Losartan—type 2 diabetes mellitus	0.000225	0.0014	CcSEcCtD
Silodosin—Skin disorder—Metformin—type 2 diabetes mellitus	0.000224	0.0014	CcSEcCtD
Silodosin—Immune system disorder—Ramipril—type 2 diabetes mellitus	0.000223	0.00139	CcSEcCtD
Silodosin—Mediastinal disorder—Ramipril—type 2 diabetes mellitus	0.000222	0.00139	CcSEcCtD
Silodosin—Dizziness—Bromocriptine—type 2 diabetes mellitus	0.000222	0.00138	CcSEcCtD
Silodosin—Dry mouth—Irbesartan—type 2 diabetes mellitus	0.000222	0.00138	CcSEcCtD
Silodosin—Palpitations—Losartan—type 2 diabetes mellitus	0.000221	0.00138	CcSEcCtD
Silodosin—Nausea—Glimepiride—type 2 diabetes mellitus	0.000221	0.00138	CcSEcCtD
Silodosin—Loss of consciousness—Losartan—type 2 diabetes mellitus	0.00022	0.00137	CcSEcCtD
Silodosin—Nausea—Sitagliptin—type 2 diabetes mellitus	0.00022	0.00137	CcSEcCtD
Silodosin—Asthenia—Glyburide—type 2 diabetes mellitus	0.00022	0.00137	CcSEcCtD
Silodosin—Urticaria—Gliclazide—type 2 diabetes mellitus	0.000219	0.00136	CcSEcCtD
Silodosin—Gastrointestinal disorder—Valsartan—type 2 diabetes mellitus	0.000218	0.00136	CcSEcCtD
Silodosin—Abdominal pain—Gliclazide—type 2 diabetes mellitus	0.000218	0.00136	CcSEcCtD
Silodosin—Pruritus—Glyburide—type 2 diabetes mellitus	0.000217	0.00135	CcSEcCtD
Silodosin—Mental disorder—Ramipril—type 2 diabetes mellitus	0.000216	0.00135	CcSEcCtD
Silodosin—Gastrointestinal disorder—Orlistat—type 2 diabetes mellitus	0.000216	0.00135	CcSEcCtD
Silodosin—Hypotension—Metformin—type 2 diabetes mellitus	0.000215	0.00134	CcSEcCtD
Silodosin—Shock—Irbesartan—type 2 diabetes mellitus	0.000214	0.00133	CcSEcCtD
Silodosin—Nervous system disorder—Irbesartan—type 2 diabetes mellitus	0.000213	0.00133	CcSEcCtD
Silodosin—Tachycardia—Irbesartan—type 2 diabetes mellitus	0.000212	0.00132	CcSEcCtD
Silodosin—Rash—Bromocriptine—type 2 diabetes mellitus	0.000211	0.00132	CcSEcCtD
Silodosin—Dermatitis—Bromocriptine—type 2 diabetes mellitus	0.000211	0.00132	CcSEcCtD
Silodosin—Skin disorder—Irbesartan—type 2 diabetes mellitus	0.000211	0.00132	CcSEcCtD
Silodosin—Headache—Bromocriptine—type 2 diabetes mellitus	0.00021	0.00131	CcSEcCtD
Silodosin—Diarrhoea—Glyburide—type 2 diabetes mellitus	0.00021	0.00131	CcSEcCtD
Silodosin—Dry mouth—Losartan—type 2 diabetes mellitus	0.000209	0.0013	CcSEcCtD
Silodosin—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	0.000207	0.00129	CcSEcCtD
Silodosin—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	0.000204	0.00127	CcSEcCtD
Silodosin—Hypotension—Irbesartan—type 2 diabetes mellitus	0.000203	0.00127	CcSEcCtD
Silodosin—Shock—Losartan—type 2 diabetes mellitus	0.000201	0.00126	CcSEcCtD
Silodosin—Urticaria—Valsartan—type 2 diabetes mellitus	0.000201	0.00125	CcSEcCtD
Silodosin—Nervous system disorder—Losartan—type 2 diabetes mellitus	0.000201	0.00125	CcSEcCtD
Silodosin—Abdominal pain—Valsartan—type 2 diabetes mellitus	0.0002	0.00125	CcSEcCtD
Silodosin—Tachycardia—Losartan—type 2 diabetes mellitus	0.0002	0.00125	CcSEcCtD
Silodosin—Nausea—Bromocriptine—type 2 diabetes mellitus	0.000199	0.00124	CcSEcCtD
Silodosin—Gastrointestinal disorder—Metformin—type 2 diabetes mellitus	0.000199	0.00124	CcSEcCtD
Silodosin—Urticaria—Orlistat—type 2 diabetes mellitus	0.000199	0.00124	CcSEcCtD
Silodosin—Abdominal pain—Orlistat—type 2 diabetes mellitus	0.000198	0.00123	CcSEcCtD
Silodosin—Asthenia—Gliclazide—type 2 diabetes mellitus	0.000197	0.00123	CcSEcCtD
Silodosin—Pruritus—Gliclazide—type 2 diabetes mellitus	0.000195	0.00121	CcSEcCtD
Silodosin—Rash—Glyburide—type 2 diabetes mellitus	0.000193	0.00121	CcSEcCtD
Silodosin—Dermatitis—Glyburide—type 2 diabetes mellitus	0.000193	0.0012	CcSEcCtD
Silodosin—Syncope—Ramipril—type 2 diabetes mellitus	0.000193	0.0012	CcSEcCtD
Silodosin—Headache—Glyburide—type 2 diabetes mellitus	0.000192	0.0012	CcSEcCtD
Silodosin—Hypotension—Losartan—type 2 diabetes mellitus	0.000191	0.00119	CcSEcCtD
Silodosin—Palpitations—Ramipril—type 2 diabetes mellitus	0.00019	0.00118	CcSEcCtD
Silodosin—Loss of consciousness—Ramipril—type 2 diabetes mellitus	0.000189	0.00118	CcSEcCtD
Silodosin—Diarrhoea—Gliclazide—type 2 diabetes mellitus	0.000188	0.00117	CcSEcCtD
Silodosin—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	0.000188	0.00117	CcSEcCtD
Silodosin—Gastrointestinal disorder—Irbesartan—type 2 diabetes mellitus	0.000188	0.00117	CcSEcCtD
Silodosin—Insomnia—Losartan—type 2 diabetes mellitus	0.000185	0.00115	CcSEcCtD
Silodosin—Urticaria—Metformin—type 2 diabetes mellitus	0.000183	0.00114	CcSEcCtD
Silodosin—Nausea—Glyburide—type 2 diabetes mellitus	0.000182	0.00114	CcSEcCtD
Silodosin—Abdominal pain—Metformin—type 2 diabetes mellitus	0.000182	0.00114	CcSEcCtD
Silodosin—Dizziness—Gliclazide—type 2 diabetes mellitus	0.000182	0.00114	CcSEcCtD
Silodosin—Unspecified disorder of skin and subcutaneous tissue—Ramipril—type 2 diabetes mellitus	0.000182	0.00113	CcSEcCtD
Silodosin—Asthenia—Valsartan—type 2 diabetes mellitus	0.000181	0.00113	CcSEcCtD
Silodosin—Asthenia—Orlistat—type 2 diabetes mellitus	0.000179	0.00112	CcSEcCtD
Silodosin—Pruritus—Valsartan—type 2 diabetes mellitus	0.000179	0.00112	CcSEcCtD
Silodosin—Dry mouth—Ramipril—type 2 diabetes mellitus	0.000179	0.00112	CcSEcCtD
Silodosin—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	0.000178	0.00111	CcSEcCtD
Silodosin—Pruritus—Orlistat—type 2 diabetes mellitus	0.000177	0.0011	CcSEcCtD
Silodosin—Rash—Gliclazide—type 2 diabetes mellitus	0.000174	0.00108	CcSEcCtD
Silodosin—Dermatitis—Gliclazide—type 2 diabetes mellitus	0.000173	0.00108	CcSEcCtD
Silodosin—Diarrhoea—Valsartan—type 2 diabetes mellitus	0.000173	0.00108	CcSEcCtD
Silodosin—Urticaria—Irbesartan—type 2 diabetes mellitus	0.000173	0.00108	CcSEcCtD
Silodosin—Shock—Ramipril—type 2 diabetes mellitus	0.000173	0.00108	CcSEcCtD
Silodosin—Headache—Gliclazide—type 2 diabetes mellitus	0.000172	0.00108	CcSEcCtD
Silodosin—Nervous system disorder—Ramipril—type 2 diabetes mellitus	0.000172	0.00107	CcSEcCtD
Silodosin—Abdominal pain—Irbesartan—type 2 diabetes mellitus	0.000172	0.00107	CcSEcCtD
Silodosin—Tachycardia—Ramipril—type 2 diabetes mellitus	0.000171	0.00107	CcSEcCtD
Silodosin—Diarrhoea—Orlistat—type 2 diabetes mellitus	0.000171	0.00107	CcSEcCtD
Silodosin—Skin disorder—Ramipril—type 2 diabetes mellitus	0.00017	0.00106	CcSEcCtD
Silodosin—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	0.000167	0.00104	CcSEcCtD
Silodosin—Dizziness—Valsartan—type 2 diabetes mellitus	0.000167	0.00104	CcSEcCtD
Silodosin—Dizziness—Orlistat—type 2 diabetes mellitus	0.000165	0.00103	CcSEcCtD
Silodosin—Asthenia—Metformin—type 2 diabetes mellitus	0.000165	0.00103	CcSEcCtD
Silodosin—Hypotension—Ramipril—type 2 diabetes mellitus	0.000164	0.00102	CcSEcCtD
Silodosin—Nausea—Gliclazide—type 2 diabetes mellitus	0.000163	0.00102	CcSEcCtD
Silodosin—Pruritus—Metformin—type 2 diabetes mellitus	0.000163	0.00102	CcSEcCtD
Silodosin—Urticaria—Losartan—type 2 diabetes mellitus	0.000162	0.00101	CcSEcCtD
Silodosin—Abdominal pain—Losartan—type 2 diabetes mellitus	0.000162	0.00101	CcSEcCtD
Silodosin—Rash—Valsartan—type 2 diabetes mellitus	0.000159	0.000995	CcSEcCtD
Silodosin—Dermatitis—Valsartan—type 2 diabetes mellitus	0.000159	0.000994	CcSEcCtD
Silodosin—Insomnia—Ramipril—type 2 diabetes mellitus	0.000159	0.00099	CcSEcCtD
Silodosin—Headache—Valsartan—type 2 diabetes mellitus	0.000158	0.000988	CcSEcCtD
Silodosin—Diarrhoea—Metformin—type 2 diabetes mellitus	0.000158	0.000983	CcSEcCtD
Silodosin—Rash—Orlistat—type 2 diabetes mellitus	0.000158	0.000983	CcSEcCtD
Silodosin—Dermatitis—Orlistat—type 2 diabetes mellitus	0.000157	0.000982	CcSEcCtD
Silodosin—Headache—Orlistat—type 2 diabetes mellitus	0.000157	0.000977	CcSEcCtD
Silodosin—Asthenia—Irbesartan—type 2 diabetes mellitus	0.000156	0.000973	CcSEcCtD
Silodosin—Pruritus—Irbesartan—type 2 diabetes mellitus	0.000154	0.000959	CcSEcCtD
Silodosin—Dizziness—Metformin—type 2 diabetes mellitus	0.000152	0.00095	CcSEcCtD
Silodosin—Gastrointestinal disorder—Ramipril—type 2 diabetes mellitus	0.000151	0.000945	CcSEcCtD
Silodosin—Nausea—Valsartan—type 2 diabetes mellitus	0.00015	0.000937	CcSEcCtD
Silodosin—Diarrhoea—Irbesartan—type 2 diabetes mellitus	0.000149	0.000928	CcSEcCtD
Silodosin—Nausea—Orlistat—type 2 diabetes mellitus	0.000148	0.000926	CcSEcCtD
Silodosin—Asthenia—Losartan—type 2 diabetes mellitus	0.000147	0.000916	CcSEcCtD
Silodosin—Rash—Metformin—type 2 diabetes mellitus	0.000145	0.000906	CcSEcCtD
Silodosin—Dermatitis—Metformin—type 2 diabetes mellitus	0.000145	0.000905	CcSEcCtD
Silodosin—Pruritus—Losartan—type 2 diabetes mellitus	0.000145	0.000903	CcSEcCtD
Silodosin—Headache—Metformin—type 2 diabetes mellitus	0.000144	0.0009	CcSEcCtD
Silodosin—Dizziness—Irbesartan—type 2 diabetes mellitus	0.000144	0.000897	CcSEcCtD
Silodosin—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	0.000143	0.000895	CcSEcCtD
Silodosin—Diarrhoea—Losartan—type 2 diabetes mellitus	0.00014	0.000873	CcSEcCtD
Silodosin—Urticaria—Ramipril—type 2 diabetes mellitus	0.000139	0.000869	CcSEcCtD
Silodosin—Abdominal pain—Ramipril—type 2 diabetes mellitus	0.000139	0.000865	CcSEcCtD
Silodosin—Rash—Irbesartan—type 2 diabetes mellitus	0.000137	0.000855	CcSEcCtD
Silodosin—Dermatitis—Irbesartan—type 2 diabetes mellitus	0.000137	0.000854	CcSEcCtD
Silodosin—Nausea—Metformin—type 2 diabetes mellitus	0.000137	0.000853	CcSEcCtD
Silodosin—Headache—Irbesartan—type 2 diabetes mellitus	0.000136	0.000849	CcSEcCtD
Silodosin—Dizziness—Losartan—type 2 diabetes mellitus	0.000135	0.000844	CcSEcCtD
Silodosin—Nausea—Irbesartan—type 2 diabetes mellitus	0.000129	0.000805	CcSEcCtD
Silodosin—Rash—Losartan—type 2 diabetes mellitus	0.000129	0.000805	CcSEcCtD
Silodosin—Dermatitis—Losartan—type 2 diabetes mellitus	0.000129	0.000804	CcSEcCtD
Silodosin—Headache—Losartan—type 2 diabetes mellitus	0.000128	0.000799	CcSEcCtD
Silodosin—Asthenia—Ramipril—type 2 diabetes mellitus	0.000126	0.000785	CcSEcCtD
Silodosin—Pruritus—Ramipril—type 2 diabetes mellitus	0.000124	0.000774	CcSEcCtD
Silodosin—Nausea—Losartan—type 2 diabetes mellitus	0.000121	0.000758	CcSEcCtD
Silodosin—Diarrhoea—Ramipril—type 2 diabetes mellitus	0.00012	0.000749	CcSEcCtD
Silodosin—Dizziness—Ramipril—type 2 diabetes mellitus	0.000116	0.000724	CcSEcCtD
Silodosin—Rash—Ramipril—type 2 diabetes mellitus	0.000111	0.00069	CcSEcCtD
Silodosin—Dermatitis—Ramipril—type 2 diabetes mellitus	0.00011	0.000689	CcSEcCtD
Silodosin—Headache—Ramipril—type 2 diabetes mellitus	0.00011	0.000685	CcSEcCtD
Silodosin—Nausea—Ramipril—type 2 diabetes mellitus	0.000104	0.00065	CcSEcCtD
Silodosin—ADRA1B—Signaling by GPCR—AKT2—type 2 diabetes mellitus	8.5e-06	7.79e-05	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—SLC2A2—type 2 diabetes mellitus	8.49e-06	7.79e-05	CbGpPWpGaD
Silodosin—ADRA1B—GPCR downstream signaling—PIK3R1—type 2 diabetes mellitus	8.49e-06	7.78e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—TCF7L2—type 2 diabetes mellitus	8.35e-06	7.66e-05	CbGpPWpGaD
Silodosin—UGT2B7—Metabolism—PIK3R1—type 2 diabetes mellitus	8.34e-06	7.64e-05	CbGpPWpGaD
Silodosin—UGT2B7—Metabolism—NOS3—type 2 diabetes mellitus	8.34e-06	7.64e-05	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—CPT1A—type 2 diabetes mellitus	8.32e-06	7.63e-05	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—MTR—type 2 diabetes mellitus	8.32e-06	7.63e-05	CbGpPWpGaD
Silodosin—ADRA1A—GPCR downstream signaling—AKT2—type 2 diabetes mellitus	8.31e-06	7.62e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—HSD17B3—type 2 diabetes mellitus	8.3e-06	7.61e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—ACACA—type 2 diabetes mellitus	8.3e-06	7.61e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—STAR—type 2 diabetes mellitus	8.3e-06	7.61e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—PTPN1—type 2 diabetes mellitus	8.21e-06	7.53e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—GCG—type 2 diabetes mellitus	8.21e-06	7.53e-05	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	8.2e-06	7.52e-05	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—NAMPT—type 2 diabetes mellitus	8.16e-06	7.48e-05	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—LIPC—type 2 diabetes mellitus	8.11e-06	7.44e-05	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—GCK—type 2 diabetes mellitus	8.11e-06	7.44e-05	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—HBA1—type 2 diabetes mellitus	8.11e-06	7.44e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—RASGRP1—type 2 diabetes mellitus	8.07e-06	7.4e-05	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—CYP11A1—type 2 diabetes mellitus	8.06e-06	7.39e-05	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—CCR5—type 2 diabetes mellitus	8.05e-06	7.38e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—NOTCH2—type 2 diabetes mellitus	8.05e-06	7.38e-05	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—TGFBR2—type 2 diabetes mellitus	8.04e-06	7.37e-05	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—GNB3—type 2 diabetes mellitus	7.96e-06	7.3e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—ABCC8—type 2 diabetes mellitus	7.96e-06	7.3e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—CBS—type 2 diabetes mellitus	7.96e-06	7.3e-05	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—SLC9A1—type 2 diabetes mellitus	7.92e-06	7.26e-05	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—C3—type 2 diabetes mellitus	7.87e-06	7.21e-05	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—AVP—type 2 diabetes mellitus	7.86e-06	7.2e-05	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—MMP3—type 2 diabetes mellitus	7.86e-06	7.2e-05	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—CETP—type 2 diabetes mellitus	7.82e-06	7.17e-05	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—IGF2—type 2 diabetes mellitus	7.82e-06	7.17e-05	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	7.79e-06	7.14e-05	CbGpPWpGaD
Silodosin—ADRA1B—Signaling by GPCR—PIK3R1—type 2 diabetes mellitus	7.71e-06	7.07e-05	CbGpPWpGaD
Silodosin—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—type 2 diabetes mellitus	7.68e-06	7.04e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling by GPCR—CCL2—type 2 diabetes mellitus	7.68e-06	7.04e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—SLC5A2—type 2 diabetes mellitus	7.66e-06	7.02e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—COX2—type 2 diabetes mellitus	7.66e-06	7.02e-05	CbGpPWpGaD
Silodosin—UGT2B7—Metabolism—PTGS2—type 2 diabetes mellitus	7.63e-06	6.99e-05	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—APOB—type 2 diabetes mellitus	7.59e-06	6.96e-05	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—IGF1R—type 2 diabetes mellitus	7.56e-06	6.94e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling by GPCR—AKT2—type 2 diabetes mellitus	7.55e-06	6.92e-05	CbGpPWpGaD
Silodosin—ADRA1A—GPCR downstream signaling—PIK3R1—type 2 diabetes mellitus	7.54e-06	6.91e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—NCOA6—type 2 diabetes mellitus	7.52e-06	6.9e-05	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—HIF1A—type 2 diabetes mellitus	7.5e-06	6.88e-05	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—IRS2—type 2 diabetes mellitus	7.48e-06	6.86e-05	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—AGT—type 2 diabetes mellitus	7.47e-06	6.85e-05	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—EDN1—type 2 diabetes mellitus	7.47e-06	6.85e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—UCP3—type 2 diabetes mellitus	7.4e-06	6.78e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—UCP2—type 2 diabetes mellitus	7.4e-06	6.78e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—HSD11B1—type 2 diabetes mellitus	7.4e-06	6.78e-05	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—CALM1—type 2 diabetes mellitus	7.35e-06	6.74e-05	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—APOE—type 2 diabetes mellitus	7.32e-06	6.71e-05	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—LEP—type 2 diabetes mellitus	7.32e-06	6.71e-05	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—PSMD6—type 2 diabetes mellitus	7.27e-06	6.67e-05	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—SNAP25—type 2 diabetes mellitus	7.27e-06	6.67e-05	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—SREBF1—type 2 diabetes mellitus	7.27e-06	6.67e-05	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—LPL—type 2 diabetes mellitus	7.25e-06	6.65e-05	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—APOA1—type 2 diabetes mellitus	7.24e-06	6.64e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—TGFBR2—type 2 diabetes mellitus	7.14e-06	6.55e-05	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—CTGF—type 2 diabetes mellitus	7.14e-06	6.55e-05	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—ADCY5—type 2 diabetes mellitus	7.1e-06	6.51e-05	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—HMGCR—type 2 diabetes mellitus	7.08e-06	6.49e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—GNB3—type 2 diabetes mellitus	7.07e-06	6.49e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—AVP—type 2 diabetes mellitus	6.98e-06	6.4e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—MMP3—type 2 diabetes mellitus	6.98e-06	6.4e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—PCK1—type 2 diabetes mellitus	6.95e-06	6.38e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—IGF2—type 2 diabetes mellitus	6.95e-06	6.37e-05	CbGpPWpGaD
Silodosin—ABCB1—Transmembrane transport of small molecules—ALB—type 2 diabetes mellitus	6.94e-06	6.36e-05	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—ADRA2A—type 2 diabetes mellitus	6.92e-06	6.35e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	6.92e-06	6.34e-05	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—PRKCB—type 2 diabetes mellitus	6.91e-06	6.33e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling by GPCR—PIK3R1—type 2 diabetes mellitus	6.85e-06	6.28e-05	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	6.8e-06	6.24e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—APOB—type 2 diabetes mellitus	6.75e-06	6.19e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—IGF1R—type 2 diabetes mellitus	6.72e-06	6.16e-05	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—CCR5—type 2 diabetes mellitus	6.68e-06	6.13e-05	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—CYP2E1—type 2 diabetes mellitus	6.65e-06	6.1e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—EDN1—type 2 diabetes mellitus	6.64e-06	6.09e-05	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—SLC2A1—type 2 diabetes mellitus	6.58e-06	6.03e-05	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—CYP1A2—type 2 diabetes mellitus	6.58e-06	6.03e-05	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—IRS1—type 2 diabetes mellitus	6.53e-06	5.99e-05	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—C3—type 2 diabetes mellitus	6.53e-06	5.99e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—HK1—type 2 diabetes mellitus	6.51e-06	5.97e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—LPL—type 2 diabetes mellitus	6.44e-06	5.91e-05	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—CYP3A4—type 2 diabetes mellitus	6.42e-06	5.88e-05	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—GCG—type 2 diabetes mellitus	6.31e-06	5.78e-05	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—SLC2A4—type 2 diabetes mellitus	6.31e-06	5.78e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—ADCY5—type 2 diabetes mellitus	6.31e-06	5.78e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—LPA—type 2 diabetes mellitus	6.29e-06	5.77e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—HSD3B2—type 2 diabetes mellitus	6.29e-06	5.77e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—GCKR—type 2 diabetes mellitus	6.29e-06	5.77e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—KCNJ11—type 2 diabetes mellitus	6.29e-06	5.77e-05	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—INS—type 2 diabetes mellitus	6.26e-06	5.74e-05	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—HIF1A—type 2 diabetes mellitus	6.23e-06	5.71e-05	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—IRS2—type 2 diabetes mellitus	6.21e-06	5.7e-05	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—AGT—type 2 diabetes mellitus	6.2e-06	5.69e-05	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—CCL2—type 2 diabetes mellitus	6.16e-06	5.64e-05	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—CALM1—type 2 diabetes mellitus	6.1e-06	5.59e-05	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—LEP—type 2 diabetes mellitus	6.08e-06	5.57e-05	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—APOE—type 2 diabetes mellitus	6.08e-06	5.57e-05	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—IGF1—type 2 diabetes mellitus	6.05e-06	5.55e-05	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—AKT2—type 2 diabetes mellitus	6.05e-06	5.54e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	6.04e-06	5.54e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—ALDOB—type 2 diabetes mellitus	6.03e-06	5.53e-05	CbGpPWpGaD
Silodosin—ADRA1D—Signaling by GPCR—EGFR—type 2 diabetes mellitus	6.02e-06	5.52e-05	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—APOA1—type 2 diabetes mellitus	6.01e-06	5.51e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—CCR5—type 2 diabetes mellitus	5.93e-06	5.44e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—C3—type 2 diabetes mellitus	5.8e-06	5.32e-05	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	5.75e-06	5.27e-05	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—PRKCB—type 2 diabetes mellitus	5.73e-06	5.26e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—GLP1R—type 2 diabetes mellitus	5.61e-06	5.14e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—HIF1A—type 2 diabetes mellitus	5.53e-06	5.07e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—IRS2—type 2 diabetes mellitus	5.52e-06	5.06e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—AGT—type 2 diabetes mellitus	5.51e-06	5.05e-05	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	5.49e-06	5.03e-05	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—NOS3—type 2 diabetes mellitus	5.49e-06	5.03e-05	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—GNB3—type 2 diabetes mellitus	5.44e-06	4.98e-05	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—PPARGC1A—type 2 diabetes mellitus	5.44e-06	4.98e-05	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—IRS1—type 2 diabetes mellitus	5.42e-06	4.97e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—CALM1—type 2 diabetes mellitus	5.42e-06	4.97e-05	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—HMOX1—type 2 diabetes mellitus	5.41e-06	4.96e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—LEP—type 2 diabetes mellitus	5.4e-06	4.95e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—APOE—type 2 diabetes mellitus	5.4e-06	4.95e-05	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—CAT—type 2 diabetes mellitus	5.34e-06	4.9e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—APOA1—type 2 diabetes mellitus	5.34e-06	4.89e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—SLC2A2—type 2 diabetes mellitus	5.23e-06	4.8e-05	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—INS—type 2 diabetes mellitus	5.19e-06	4.76e-05	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—APOB—type 2 diabetes mellitus	5.18e-06	4.75e-05	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—RELA—type 2 diabetes mellitus	5.16e-06	4.74e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—CPT1A—type 2 diabetes mellitus	5.13e-06	4.7e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—MTR—type 2 diabetes mellitus	5.13e-06	4.7e-05	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—CCL2—type 2 diabetes mellitus	5.11e-06	4.68e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—PRKCB—type 2 diabetes mellitus	5.09e-06	4.67e-05	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—GSTM1—type 2 diabetes mellitus	5.04e-06	4.62e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—NAMPT—type 2 diabetes mellitus	5.03e-06	4.61e-05	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—IGF1—type 2 diabetes mellitus	5.02e-06	4.61e-05	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—AKT2—type 2 diabetes mellitus	5.02e-06	4.6e-05	CbGpPWpGaD
Silodosin—ADRA1B—Signaling by GPCR—EGFR—type 2 diabetes mellitus	5e-06	4.58e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—HBA1—type 2 diabetes mellitus	5e-06	4.58e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—LIPC—type 2 diabetes mellitus	5e-06	4.58e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—GCK—type 2 diabetes mellitus	5e-06	4.58e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—CYP11A1—type 2 diabetes mellitus	4.97e-06	4.55e-05	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—LPL—type 2 diabetes mellitus	4.95e-06	4.54e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—SLC9A1—type 2 diabetes mellitus	4.88e-06	4.47e-05	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—ADCY5—type 2 diabetes mellitus	4.84e-06	4.44e-05	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—GPX1—type 2 diabetes mellitus	4.83e-06	4.43e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—CETP—type 2 diabetes mellitus	4.82e-06	4.42e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—IRS1—type 2 diabetes mellitus	4.82e-06	4.42e-05	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	4.77e-06	4.37e-05	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—CD36—type 2 diabetes mellitus	4.7e-06	4.31e-05	CbGpPWpGaD
Silodosin—ADRA1D—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	4.7e-06	4.31e-05	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—CASP3—type 2 diabetes mellitus	4.66e-06	4.27e-05	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—PPP2CA—type 2 diabetes mellitus	4.64e-06	4.26e-05	CbGpPWpGaD
Silodosin—ADRA1D—Signaling by GPCR—IL6—type 2 diabetes mellitus	4.63e-06	4.24e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—INS—type 2 diabetes mellitus	4.61e-06	4.23e-05	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—NOS3—type 2 diabetes mellitus	4.55e-06	4.18e-05	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	4.55e-06	4.18e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—CCL2—type 2 diabetes mellitus	4.54e-06	4.16e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—SNAP25—type 2 diabetes mellitus	4.48e-06	4.11e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—PSMD6—type 2 diabetes mellitus	4.48e-06	4.11e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—SREBF1—type 2 diabetes mellitus	4.48e-06	4.11e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—IGF1—type 2 diabetes mellitus	4.46e-06	4.09e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—AKT2—type 2 diabetes mellitus	4.46e-06	4.09e-05	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—MTHFR—type 2 diabetes mellitus	4.46e-06	4.09e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling by GPCR—EGFR—type 2 diabetes mellitus	4.44e-06	4.07e-05	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—MMP9—type 2 diabetes mellitus	4.4e-06	4.04e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—CTGF—type 2 diabetes mellitus	4.4e-06	4.03e-05	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—PPARA—type 2 diabetes mellitus	4.37e-06	4.01e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—HMGCR—type 2 diabetes mellitus	4.36e-06	4e-05	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—NFKB1—type 2 diabetes mellitus	4.35e-06	3.99e-05	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—RELA—type 2 diabetes mellitus	4.29e-06	3.93e-05	CbGpPWpGaD
Silodosin—ADRA1D—Signaling by GPCR—AKT1—type 2 diabetes mellitus	4.27e-06	3.91e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—ADRA2A—type 2 diabetes mellitus	4.27e-06	3.91e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	4.24e-06	3.88e-05	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—AGT—type 2 diabetes mellitus	4.23e-06	3.88e-05	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—CALM1—type 2 diabetes mellitus	4.16e-06	3.82e-05	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—APOE—type 2 diabetes mellitus	4.15e-06	3.8e-05	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—APOA1—type 2 diabetes mellitus	4.1e-06	3.76e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—CYP2E1—type 2 diabetes mellitus	4.1e-06	3.76e-05	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—SRC—type 2 diabetes mellitus	4.06e-06	3.72e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—SLC2A1—type 2 diabetes mellitus	4.05e-06	3.72e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—CYP1A2—type 2 diabetes mellitus	4.05e-06	3.72e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	4.04e-06	3.71e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—NOS3—type 2 diabetes mellitus	4.04e-06	3.71e-05	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—VEGFA—type 2 diabetes mellitus	3.95e-06	3.62e-05	CbGpPWpGaD
Silodosin—ADRA1B—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	3.9e-06	3.58e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—GCG—type 2 diabetes mellitus	3.89e-06	3.56e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—SLC2A4—type 2 diabetes mellitus	3.89e-06	3.56e-05	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—CASP3—type 2 diabetes mellitus	3.87e-06	3.54e-05	CbGpPWpGaD
Silodosin—ADRA1B—Signaling by GPCR—IL6—type 2 diabetes mellitus	3.84e-06	3.52e-05	CbGpPWpGaD
Silodosin—UGT2B7—Metabolism—AKT1—type 2 diabetes mellitus	3.83e-06	3.51e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—RELA—type 2 diabetes mellitus	3.81e-06	3.49e-05	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—MMP9—type 2 diabetes mellitus	3.65e-06	3.35e-05	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—TGFB1—type 2 diabetes mellitus	3.63e-06	3.33e-05	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—NFKB1—type 2 diabetes mellitus	3.61e-06	3.31e-05	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—PPARG—type 2 diabetes mellitus	3.61e-06	3.31e-05	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—EGFR—type 2 diabetes mellitus	3.56e-06	3.26e-05	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—INS—type 2 diabetes mellitus	3.54e-06	3.25e-05	CbGpPWpGaD
Silodosin—ADRA1B—Signaling by GPCR—AKT1—type 2 diabetes mellitus	3.54e-06	3.25e-05	CbGpPWpGaD
Silodosin—ADRA1A—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	3.47e-06	3.18e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—CASP3—type 2 diabetes mellitus	3.43e-06	3.15e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling by GPCR—IL6—type 2 diabetes mellitus	3.41e-06	3.13e-05	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—SRC—type 2 diabetes mellitus	3.37e-06	3.09e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—GNB3—type 2 diabetes mellitus	3.35e-06	3.07e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—PPARGC1A—type 2 diabetes mellitus	3.35e-06	3.07e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—HMOX1—type 2 diabetes mellitus	3.33e-06	3.06e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—CAT—type 2 diabetes mellitus	3.29e-06	3.02e-05	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—VEGFA—type 2 diabetes mellitus	3.28e-06	3.01e-05	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—ALB—type 2 diabetes mellitus	3.25e-06	2.98e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—MMP9—type 2 diabetes mellitus	3.25e-06	2.98e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—NFKB1—type 2 diabetes mellitus	3.21e-06	2.94e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—APOB—type 2 diabetes mellitus	3.19e-06	2.93e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling by GPCR—AKT1—type 2 diabetes mellitus	3.15e-06	2.89e-05	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—NOS3—type 2 diabetes mellitus	3.11e-06	2.85e-05	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—PIK3R1—type 2 diabetes mellitus	3.11e-06	2.85e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—GSTM1—type 2 diabetes mellitus	3.11e-06	2.85e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—LPL—type 2 diabetes mellitus	3.05e-06	2.8e-05	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—TGFB1—type 2 diabetes mellitus	3.01e-06	2.76e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—SRC—type 2 diabetes mellitus	2.99e-06	2.74e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—ADCY5—type 2 diabetes mellitus	2.98e-06	2.74e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—GPX1—type 2 diabetes mellitus	2.97e-06	2.73e-05	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—EGFR—type 2 diabetes mellitus	2.95e-06	2.71e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—VEGFA—type 2 diabetes mellitus	2.91e-06	2.67e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—CD36—type 2 diabetes mellitus	2.9e-06	2.66e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—PPP2CA—type 2 diabetes mellitus	2.86e-06	2.62e-05	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—PTGS2—type 2 diabetes mellitus	2.84e-06	2.61e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—MTHFR—type 2 diabetes mellitus	2.75e-06	2.52e-05	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—IL6—type 2 diabetes mellitus	2.73e-06	2.51e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—PPARA—type 2 diabetes mellitus	2.69e-06	2.47e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—TGFB1—type 2 diabetes mellitus	2.67e-06	2.45e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—EGFR—type 2 diabetes mellitus	2.62e-06	2.4e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—AGT—type 2 diabetes mellitus	2.61e-06	2.39e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—CALM1—type 2 diabetes mellitus	2.56e-06	2.35e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—APOE—type 2 diabetes mellitus	2.56e-06	2.34e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—APOA1—type 2 diabetes mellitus	2.53e-06	2.32e-05	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—AKT1—type 2 diabetes mellitus	2.52e-06	2.31e-05	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—IL6—type 2 diabetes mellitus	2.27e-06	2.08e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—PPARG—type 2 diabetes mellitus	2.23e-06	2.04e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—INS—type 2 diabetes mellitus	2.18e-06	2e-05	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—AKT1—type 2 diabetes mellitus	2.09e-06	1.92e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—IL6—type 2 diabetes mellitus	2.02e-06	1.85e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—ALB—type 2 diabetes mellitus	2e-06	1.84e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—PIK3R1—type 2 diabetes mellitus	1.91e-06	1.76e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—NOS3—type 2 diabetes mellitus	1.91e-06	1.76e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—AKT1—type 2 diabetes mellitus	1.86e-06	1.7e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—PTGS2—type 2 diabetes mellitus	1.75e-06	1.61e-05	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—AKT1—type 2 diabetes mellitus	1.43e-06	1.31e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—AKT1—type 2 diabetes mellitus	8.8e-07	8.07e-06	CbGpPWpGaD
